SymBio Pharmaceuticals
SymBio Pharmaceuticals aims to develop drugs for patients overlooked by the industry, ensuring vital treatments reach those in need.
Market cap
$64.4m
Enterprise value
$42m
Share price
JPY170.00 4582.T
Authorizing premium user...